SCOTT SHAPIRO: Open Payments
NPI 1912519737 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,148 in 176 payments from 30 companies in 2025. Trend: 2023 $2,837 · 2024 $3,194 · 2025 $3,148
Food & beverage: $3,148
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $292 |
| Lilly USA, LLC | 19 | $259 |
| Amgen Inc. | 13 | $245 |
| Mannkind Corporation | 13 | $239 |
| Sequel Med Tech, LLC | 9 | $187 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $187 |
| Dexcom, Inc. | 14 | $176 |
| Xeris Pharmaceuticals, Inc. | 8 | $144 |
| SANOFI-AVENTIS U.S. LLC | 5 | $139 |
| Amneal Pharmaceuticals LLC | 15 | $136 |
Products named: AFREZZA, JARDIANCE, TWIIST, MOUNJARO, Dexcom G6 Transmitter, TZIELD, UNITHROID, XYOSTED.
Industry payments across FL — which companies pay providers there.
